145 related articles for article (PubMed ID: 15862755)
1. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry.
van Spronsen DJ; Janssen-Heijnen ML; Lemmens VE; Peters WG; Coebergh JW
Eur J Cancer; 2005 May; 41(7):1051-7. PubMed ID: 15862755
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index.
Janssen-Heijnen ML; van Spronsen DJ; Lemmens VE; Houterman S; Verheij KD; Coebergh JW
Br J Haematol; 2005 Jun; 129(5):597-606. PubMed ID: 15916681
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
4. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
[TBL] [Abstract][Full Text] [Related]
5. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study.
Maas HA; Kruitwagen RF; Lemmens VE; Goey SH; Janssen-Heijnen ML
Gynecol Oncol; 2005 Apr; 97(1):104-9. PubMed ID: 15790445
[TBL] [Abstract][Full Text] [Related]
6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996.
van Spronsen DJ; Janssen-Heijnen ML; Breed WP; Coebergh JW
Ann Hematol; 1999 Jul; 78(7):315-9. PubMed ID: 10466443
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
10. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
11. [The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001].
Janssen-Heijnen ML; Maas HA; Lemmens VE; Houterman S; Louwman WJ; Verheij CD; Coebergh JW
Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1686-90. PubMed ID: 16104115
[TBL] [Abstract][Full Text] [Related]
12. Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma.
Moser EC; Kluin-Nelemans HC; Carde P; Meerwaldt JH; Tirelli U; Aleman BM; Baars J; Thomas J; van Glabbeke M; Noordijk EM
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1168-77. PubMed ID: 16887289
[TBL] [Abstract][Full Text] [Related]
13. COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient.
van de Schans SA; Janssen-Heijnen ML; Biesma B; Smeenk FW; van de Poll-Franse LV; Seynaeve C; Coebergh JW
Eur J Cancer; 2007 Oct; 43(15):2194-202. PubMed ID: 17884463
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
15. Treatment and survival for non-Hodgkin's lymphoma: influence of histological subtype, age, and other factors in a population-based study (1999-2001).
Cronin-Fenton DP; Sharp L; Deady S; Comber H
Eur J Cancer; 2006 Nov; 42(16):2786-93. PubMed ID: 16930993
[TBL] [Abstract][Full Text] [Related]
16. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
[TBL] [Abstract][Full Text] [Related]
17. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
18. Cost determinants in aggressive non-Hodgkin's lymphoma.
van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.
Fu P; van Heeckeren WJ; Wadhwa PD; Bajor DJ; Creger RJ; Xu Z; Cooper BW; Laughlin MJ; Gerson SL; Koç ON; Lazarus HM
Contemp Clin Trials; 2008 Mar; 29(2):157-64. PubMed ID: 17707140
[TBL] [Abstract][Full Text] [Related]
20. Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study.
Mols F; Vingerhoets AJ; Coebergh JW; Vreugdenhil G; Aaronson NK; Lybeert ML; van de Poll-Franse LV
Eur J Cancer; 2006 Nov; 42(16):2794-801. PubMed ID: 16996260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
